The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Title:The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Volume: 16 Issue: 2

Author(s): Gholamreza Azizi, Hassan Abolhassani, Mohammad Hosein Asgardoon, Javad Rahnavard, Majid Zaki dizaji, Reza Yazdani, Javad Mohammadi and Asghar Aghamohammadi

Affiliation:

Keywords: Immunoglobulin, infection, primary antibody deficiency, primary immunodeficiency diseases.

Abstract: Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products.

Cite this article as:

Azizi Gholamreza, Abolhassani Hassan, Asgardoon Hosein Mohammad, Rahnavard Javad, dizaji Zaki Majid, Yazdani Reza, Mohammadi Javad and Aghamohammadi Asghar, The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases, Endocrine, Metabolic & Immune Disorders - Drug Targets 2016; 16 (2) . https://dx.doi.org/10.2174/1871530316666160724214418